Innovation Seed Fund
Through our Innovation Seed Fund grants, we aim to pump-prime innovative research into the causes, treatment and diagnosis of hearing loss, tinnitus and other hearing-related conditions.
We want to support novel research ideas with the aim of making them more competitive and able to secure follow-on funding.
The fund will also support small-scale projects at the translational stage, such as proof-of-concept studies or pre-clinical validation studies, again with the aim of making novel approaches more competitive for further funding.
All proposals should be able to demonstrate how they will contribute to ultimately bringing benefit to people with hearing loss, tinnitus or other hearing-related conditions. They should be highly novel and/or innovative – potentially risky ideas are welcome.
Awards are usually made in March each year.
Please note: the Innovation Seed Fund is replacing our Flexi Grant scheme from 2022.
Selection procedure :
All proposals are reviewed by our Innovation Seed Fund review panel (usually three members per proposal). They judge the scientific merit of the proposal, as well as its novelty and feasibility. RNID use these reviews to select the best projects to fund.
Applicants will be notified of the outcome as soon as possible, usually within three months of the application deadline.
Everyone involved in the review process of any grant application is asked to abide by our code of conduct.
For more information:
If you would like more information about the Innovation Seed Fund, please contact:
Call 020 3227 6159 Email email@example.com
Applicants can be from a university, research institute, or small or medium enterprise based anywhere in the world.